[1]张文博,彭媛,聂红平.血清可溶性肿瘤坏死因子受体与2型糖尿病视网膜病变相关性研究[J].眼科新进展,2016,36(7):662-666.[doi:10.13389/j.cnki.rao.2016.0176]
　ZHANG Wen-Bo,PENG-Yuan,NIE Hong-Ping.Association between sTNFR and diabetic retinopathy in type 2 diabetic patients[J].Recent Advances in Ophthalmology,2016,36(7):662-666.[doi:10.13389/j.cnki.rao.2016.0176]
点击复制

血清可溶性肿瘤坏死因子受体与2型糖尿病视网膜病变相关性研究
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
36卷
期数:
2016年7期
页码:
662-666
栏目:
应用研究
出版日期:
2016-07-05

文章信息/Info

Title:
Association between sTNFR and diabetic retinopathy in type 2 diabetic patients
作者:
张文博; 彭媛; 聂红平
100034　北京市，北京大学第一医院眼科，视觉损伤与修复教育部重点实验室
Author(s):
ZHANG Wen-Bo ;  PENG-Yuan ;  NIE Hong-Ping
Department of Ophthalmology,Peking University First Hospital, Key Laboratory of Vision Loss and RestoratLon of Ministry of Education,Beijing 100034?¬China
关键词:
糖尿病视网膜病变; 肿瘤坏死因子受体; 相关性研究
Keywords:
diabetic retinopathy ;  tumor necrosis factor receptor;  correlation analysis
分类号:
Ｒ７７４
DOI:
10.13389/j.cnki.rao.2016.0176
文献标志码:
A
摘要:
目的　研究血清可溶性肿瘤坏死因子受体（ｓｏｌｕｂｌｅｔｕｍｏｒｎｅｃｒｏｓｉｓｆａｃｔｏｒｒｅｃｅｐｔｏｒ，ｓＴＮＦＲ）与２型糖尿病视网膜病变的相关性。方法　６６例２型糖尿病患者通过眼底检查和眼底荧光血管造影按照ＥＤＴＲＳ分期分为３组：无糖尿病视网膜病变（ｎｏｄｉａｂｅｔｉｃｒｅｔｉｎｏｐａｔｈｙ，ＮＤＲ；ｎ＝２２）组、非增殖型糖尿病视网膜病变（ｎｏｎｐｒｏｌｉｆｅｒａｔｉｖｅｄｉａｂｅｔｉｃｒｅｔｉｎｏｐａｔｈｙ，ＮＰＤＲ；ｎ＝２４）组和增殖型糖尿病视网膜病变（ｐｒｏｌｉｆｅｒａｔｉｖｅｄｉａｂｅｔｉｃｒｅｔｉｎｏｐａｔｈｙ，ＰＤＲ；ｎ＝２０）组。２１名健康人作为对照组。检测４组研究对象血清中肿瘤坏死因子（ｔｕｍｏｒｎｅｃｒｏｓｉｓｆａｃｔｏｒ，ＴＮＦ）-α、ｓＴＮＦＲ-１、ｓＴＮＦＲ-２水平。组间统计分析采用非参数Ｍａｎｎ-ＷｈｉｔｎｅｙＵ检验。结果　血清中ＴＮＦ-α中位数分别为：对照组０ｐｇ·ｍＬ－１、ＮＤＲ组３．４５ｐｇ·ｍＬ－１、ＮＰＤＲ组３．９２ｐｇ·ｍＬ－１、ＰＤＲ组８．１２ｐｇ·ｍＬ－１。对照组与ＰＤＲ组（Ｐ＜０．００１）、ＮＤＲ组与ＰＤＲ组（Ｐ＝０．００８）比较差异均有统计学意义。血清中ｓＴＮＦＲ-１水平中位数：对照组１．５０ｎｇ·ｍＬ－１、ＮＤＲ组１．８８ｎｇ·ｍＬ－１、ＮＰＤＲ组２．５８ｎｇ·ｍＬ－１、ＰＤＲ组３．００ｎｇ·ｍＬ－１。对照组与ＮＰＤＲ组（Ｐ＜０．００１）、对照组与ＰＤＲ组（Ｐ＜０．００１）、ＮＤＲ组与ＮＰＤＲ组（Ｐ＝０．００７）、ＮＤＲ组与ＰＤＲ组（Ｐ＜０．００１）比较，差异均有统计学意义。血清中ｓＴ-ＮＦＲ-２中位数分别为：对照组３．８８ｎｇ·ｍＬ－１、ＮＤＲ组５．０１ｎｇ·ｍＬ－１、ＮＰＤＲ组５．２１ｎｇ·ｍＬ－１、ＰＤＲ组６．３３ｎｇ·ｍＬ－１。除了ＮＤＲ组与ＮＰＤＲ组（Ｐ＝０．０７０）间差异无统计学意义外，其他组间差异均有统计学意义（均为Ｐ＜０．０５）。结论　血清中ｓＴＮＦＲ与２型糖尿病视网膜病变密切相关，表明ｓＴＮＦＲ在糖尿病视网膜病变的发生发展中起到了一定的作用。对ｓＴＮＦＲ进行进一步研究可以寻找治疗糖尿病视网膜病变新的靶点。
Abstract:
Objective To investigate the associations of serum levels of soluble tumor necrosis factor receptor ( sTNFR) with diabetic retinopathy in type 2 diabetic patients. Methods A cross-sectional design was utilized for this study. 66 patients with type 2 diabetes underwent fundus exanunation or fundus fluorescein angiography according to the Early Treatment Diabetic Retinopathy Study ( EDTRS) and were divided into three groups : no diabetic retinopathy ( NDR , n = 22) ,non-proliferative diabetic retinopathy ( NPDR . n = 24 ) and proliferative diabetic retinopathy ( PDR . n = 20 ) . 21 healthy subjects were enrolled for control group. Serum levels of tumor necrosis factor ( TNF) -eL ,sTNFR-I and sTNFR-2 were analyzed. Statistical analysis was performed using nonparametric Mann-Whitney U test. Results The median serum TNF-e/ levels was 0 pg . mL-1 in control group,3. 45 pg . mL-1 in NDR group,3. 92 pg . mL-l in NPDR group and 8. 12 pg . mL-l in PDR group. Statistical significances were found between control group and PDR group (P < 0. 001) . NDR group and PDR group (P = 0. 008 ) . The median serum sTNFR-I levels was l. 50 ng . mL -l in control group , 1. 88 ng . mL -l in NDR group,2. 58 ng . mL -l in NPDR group and 3. 00 ng . mL -l in PDR group. Statistical significances were found between control group and NPDR group ( P < 0. 001 ) , control group and PDR group (P < 0. 001 ) , NDR group and NPDR group (P = 0. 007 ) . NDR group and PDR group ( P < 0. 001) . The median serum sTNFR-2 levels was 3. 88 ng ’ mL-1 in control group,5. 01 ng . mL -l in NDR group , 5. 21 ng . mL-l in NPDR group and 6. 33 ng ’ mL-l in PDR group. Statistical significances were found between all groups (P < 0. 05 ) , except between group NDR group and NPDR group (P = 0. 07 ) . Conclusion The serum levels of sTNFR-I . sTNFR-2 .TNF-e/are highly correlated with DR in type 2 diabetic patients , suggesting that sTNFR may play an important role in the development of DR. Research for sTNFR may be able to find a new therapeutic targets for DR.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.

更新日期/Last Update: 2016-07-12